Hypoxia Inducible Factors (hifs) - Cancer Science

Relevant Publications

Hypoxia-inducible factors in postnatal mouse molar dental pulp development: insights into expression patterns, localisation and metabolic pathways.

Issue Release: 2024

Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.

Issue Release: 2024

HIF2α-dependent Dock4/Rac1-signaling regulates formation of adherens junctions and cell polarity in normoxia.

Issue Release: 2024

Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism.

Issue Release: 2024

The Emerging Role of Hypoxia and Environmental Factors in Inflammatory Bowel Disease.

Issue Release: 2024

Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome.

Issue Release: 2024

Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication.

Issue Release: 2024

Hypoxia-inducible PRMT2 addiction in glioblastomas.

Issue Release: 2024

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.

Issue Release: 2024

Increased HIF-2α activity in the nucleus pulposus causes intervertebral disc degeneration in the aging mouse spine.

Issue Release: 2024

SPATA20 deficiency enhances the metastatic and angiogenic potential of cancer cells by promoting HIF-1α synthesis.

Issue Release: 2024

The effect of baseline O conditions on the response of prostate cancer cells to hypoxia.

Issue Release: 2024

VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.

Issue Release: 2024

PDGFRβ + cell HIF2α is dispensable for white adipose tissue metabolic remodeling and hepatic lipid accumulation in obese mice.

Issue Release: 2024

Bhlhe40 Regulates Proliferation and Angiogenesis in Mouse Embryoid Bodies under Hypoxia.

Issue Release: 2024

Hypoxia and the Hypoxia-Inducible Factors in Lymphocyte Differentiation and Function.

Issue Release: 2024

Deubiquitinating enzyme mutagenesis screens identify a USP43-dependent HIF-1 transcriptional response.

Issue Release: 2024

The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes.

Issue Release: 2024

Enzymes in Addressing Hypoxia for Biomaterials Engineering.

Issue Release: 2024

Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors.

Issue Release: 2024

What Are the Key Skills Required for a Cancer Nurse?

RYR1 and Cancer: What is the Connection?

How Are Computational Techniques Transforming the Future of Cancer Research?

What is the Role of Social Support?

What are the Symptoms of ATLL?

Can antifungals interact with cancer therapies?

What is the Future of the Milan Criteria?

What Molecular Mechanisms Regulate Lamellipodia and Filopodia?

Can Cancerous Masses be Prevented?

What Are the Challenges in Targeting Reach Regulation?

Partnered Content Networks

Relevant Topics